In a nutshell, progesterone may promote the development of IFG and T2DM and affect glucose homeostasis markers by leading to increased IR and decreased glucose intake, reducing insulin release, and inducing apoptotic death of insulin-producing cells. This evidence concerns the gene INS and type 2 diabetes mellitus.